Phibro Animal Health Corporation
PAHCPhibro Animal Health Corporation is a global provider of animal health and mineral nutrition products, serving the livestock and companion animal sectors.
Earnings
Next report
Nov 4, 2026 (in 2 months)Valuation & ratios
Competitors
By market cap
By revenue growth
By net margin
Profile
Phibro Animal Health Corporation is a global provider of animal health and mineral nutrition products, serving the livestock and companion animal sectors. The company develops and manufactures solutions to prevent and treat diseases while enhancing animal well-being across poultry, cattle, swine, and aquaculture markets. Additionally, it maintains a performance products division that supplies ingredients for industrial and personal care applications.
A leading global diversified animal health company with a significant presence in the medicated feed additive market following strategic acquisitions.
FAQ
- What is Phibro Animal Health Corporation's market cap?
- Phibro Animal Health Corporation (PAHC) has a market capitalization of $1.4B and trades on NASDAQ.
- What is Phibro Animal Health Corporation's revenue and profitability?
- Phibro Animal Health Corporation generated $1.5B in trailing twelve-month revenue with net income of $99.7M, representing a net margin of 6.6%. Gross margin stands at 33.8%, with free cash flow of $9.9M. The latest reported period is Q4 2026.
- Who are Phibro Animal Health Corporation's competitors?
- Phibro Animal Health Corporation's key competitors include Elanco Animal Health, Merck & Co., Inc., Zoetis Inc., and others. These companies compete in similar markets and product categories.
- Where is Phibro Animal Health Corporation headquartered?
- Phibro Animal Health Corporation is headquartered in United States of America and employs approximately 1,920 people. It has been publicly traded since 2014.
